Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Select Medical Holdings (SEM) EBITDA Margin (2018 - 2026)

Select Medical Holdings (SEM) has disclosed EBITDA Margin for 9 consecutive years, with 6.92% as the latest value for Q1 2026.

  • For Q1 2026, EBITDA Margin fell 141.0% year-over-year to 6.92%; the TTM value through Mar 2026 reached 5.83%, up 80.0%, while the annual FY2025 figure was 8.71%, 81.0% up from the prior year.
  • EBITDA Margin hit 6.92% in Q1 2026 for Select Medical Holdings, up from 4.58% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 120.13% in Q4 2022 and bottomed at 14.23% in Q4 2023.
  • Average EBITDA Margin over 5 years is 12.63%, with a median of 6.5% recorded in 2022.
  • Year-over-year, EBITDA Margin soared 11516bps in 2022 and then crashed -13436bps in 2023.
  • Select Medical Holdings' EBITDA Margin stood at 120.13% in 2022, then tumbled by -112bps to 14.23% in 2023, then soared by 111bps to 1.61% in 2024, then soared by 185bps to 4.58% in 2025, then soared by 51bps to 6.92% in 2026.
  • According to Business Quant data, EBITDA Margin over the past three periods came in at 6.92%, 4.58%, and 5.35% for Q1 2026, Q4 2025, and Q3 2025 respectively.